1. PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-Cetuximab(C) versus 5FU-P-C in recurrent/metastatic HNSCC. (February 2015) Authors: Guigay, J.; Keilholz, U.; Mesia, R.; Vintonenko, N.; Bourhis, J.; Auperin, A. Journal: Radiotherapy and oncology Issue: Volume 114(2015:Jan.)Supplement 1 Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-147: The ELAN program: Customised treatment of SCCHN elderly patients according to geriatric assessment. (March 2017) Authors: Guigay (France), J.; Ortholan, C.; Le Caer, H.; Renardoldrini, S.; Sun, X.; Mayache-badis, L.; Geoffrois, L.; Fayette, J.; Even, C.; Vansteene, D.; Pointreau, Y.; Schwob, D.; Vintonenko, N.; Michel, C.; Bourhis, J.; Auperin, A.; Mertens, C. Journal: Radiotherapy and oncology Issue: Volume 122(2017)Supplement 1 Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗